NASDAQ:RANI

Rani Therapeutics Holdings Stock Forecast

etoro logo Buy RANI
*Your capital is at risk
$0.782
+0.0172 (+2.25%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of RANI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RANI to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Rani Therapeutics Holdings, Inc. stock upgraded from Strong Sell Candidate to Sell Candidate after Thursday trading session
(Updated on Jun 18, 2026)

Sell candidate since May 29, 2026 Loss -17.71%

The Rani Therapeutics Holdings, Inc. stock price gained 2.25% on the last trading day (Thursday, 18th Jun 2026), rising from $0.765 to $0.782. During the last trading day the stock fluctuated 3.10% from a day low at $0.767 to a day high of $0.790. The price has been going up and down for this period, and there has been a -12.93% loss for the last 2 weeks. Volume fell on the last day by -254 thousand shares and in total, 302 thousand shares were bought and sold for approximately $236.16 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.86% during the next 3 months and, with a 90% probability hold a price between $0.603 and $0.99 at the end of this 3-month period.

RANI Signals & Forecast

There are mixed signals in the stock today. The Rani Therapeutics Holdings, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.92. On a fall, the stock will find some support from the short-term average at $0.774. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 2.99%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Rani Therapeutics Holdings, Inc. stock

Rani Therapeutics Holdings, Inc. finds support from accumulated volume at $0.780 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0238 between high and low, or 3.10%. For the last week the stock has had daily average volatility of 5.87%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RANI) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Rani Therapeutics Holdings, Inc. to open at $0.780, and during the day (based on 14 day Average True Range), to move between $0.750 and $0.81, which gives a possible trading interval of +/-$0.0642 (+/-8.55%) up or down from last closing price. If Rani Therapeutics Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 8.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.780 (0.31%) than the resistance at $0.81 (2.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Rani Therapeutics Holdings, Inc. stock A Buy?

Rani Therapeutics Holdings, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.618 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $0.780 ( 0.332%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RANI Performance

Trading levels for RANI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.80 2.71%
R2 0.795 1.55%
R1 0.789 0.83%
Price 0.782
S1 0.771 -1.49%
S2 0.765 -2.21%
S3 0.756 -3.37%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.90 14.48%
R2 0.81 3.60%
R1 0.81 2.94%
Price 0.782
S1 0.780 -0.307%
S2 0.763 -2.47%
S3 0.735 -6.08%

FAQ

What is the symbol for Rani Therapeutics Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Rani Therapeutics Holdings, Inc. is RANI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rani Therapeutics Holdings, Inc. Stock?
Rani Therapeutics Holdings, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Rani Therapeutics Holdings, Inc. Stock?
Rani Therapeutics Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rani Therapeutics Holdings, Inc. Stock.

What's the current price of Rani Therapeutics Holdings, Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Rani Therapeutics Holdings, Inc. (RANI) share was $0.782.

What is the 52-week high and low for Rani Therapeutics Holdings, Inc. Stock?
The 52-week high for Rani Therapeutics Holdings, Inc. Stock is $3.87 and the 52-week low is $0.387.

What is the market capitalization of Rani Therapeutics Holdings, Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Rani Therapeutics Holdings, Inc. is 51.106M.

When is the next earnings date for Rani Therapeutics Holdings, Inc.?
The upcoming earnings date for Rani Therapeutics Holdings, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT RANI THERAPEUTICS HOLDINGS, INC.
Rani Therapeutics Holdings
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-al...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE